SCHEMBL7811475

SCHEMBL7811475

NCC(=O)NCCNc1cc(-c2ccnc(Nc3cccc(Cl)c3)n2)ccn1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CSNK2A1 P68400 3/20 0.75
▸ CDK1 P06493 6/20 0.70
▸ CDK2 P24941 4/20 0.70
▸ SMG1 Q96Q15 3/20 0.70
▸ MTOR P42345 2/20 0.70
▸ CDK4 P11802 2/20 0.70
▸ CCNB1 P14635 2/20 0.70
▸ CCNA2 P20248 2/20 0.70
▸ CCND1 P24385 2/20 0.70
▸ CDK7 P50613 2/20 0.70
▸ CCNH P51946 2/20 0.70
▸ CDK5 Q00535 2/20 0.70
▸ CDK5R1 Q15078 2/20 0.70
▸ MAPT P10636 2/20 0.70
▸ NPC1 O15118 1/20 0.70
▸ CCNT1 O60563 1/20 0.70
▸ XBP1 P17861 1/20 0.70
▸ CCNE1 P24864 1/20 0.70
▸ MAPK1 P28482 1/20 0.70
▸ HTT P42858 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6107317 0.89 CDK1 (0.72) CSNK2A1CDK1CDK2SMG1MTOR
SCHEMBL6107247 0.87 CDK1 (0.70) CSNK2A1CDK1CDK2SMG1MTOR
SCHEMBL6107651 0.86 CSNK2A1 (1.00) CSNK2A1CDK1CDK2SMG1MTOR
SCHEMBL6110484 0.86 CSNK2A1 (0.76) CSNK2A1CDK1CDK2SMG1MTOR
SCHEMBL6109943 0.85 CDK1 (0.72) CSNK2A1CDK1CDK2SMG1MTOR
SCHEMBL6109413 0.85 CDK1 (0.75) CSNK2A1CDK1CDK2SMG1MTOR
Monoethanolamine SCHEMBL7817266 0.85 CSNK2A1 (0.85) CSNK2A1CDK1CDK2SMG1MTOR
SCHEMBL6094407 0.84 CDK1 (0.88) CSNK2A1CDK1CDK2SMG1MTOR
SCHEMBL7817083 0.84 CDK1 (0.91) CSNK2A1CDK1CDK2SMG1MTOR
SCHEMBL7813759 0.83 CDK1 (0.85) CSNK2A1CDK1CDK2SMG1MTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0672041-B1 PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF NOVARTIS AG (CH) 2001-11-14 — — EP disclosed
EP-0672041-A1 PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF Novartis AG (CH) 1995-09-20 — — EP disclosed
WO-1995009853-A1 PHARMACOLOGICALLY ACTIVE PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF CIBA-GEIGY AG (CH) 1995-04-13 — — WO disclosed
Send feedback